Biotricity, Inc.: Biotricity Unveils That Improved Margins Resulted From Latest Advancements To Its Proprietary Cardiac Ai Cloud Platform And Announces Plans For Continued Expansion Of Its Cardiac Ai Cloud

Biotricity is expanding its Cardiac AI platform to support clinical decisions and increase operational efficiency in the healthcare industry. The company expects to file for FDA clearance by the end of the year, as the healthcare AI market is projected to reach $208.2 billion by 2030.